Author:
Zekja Ilirjana,Kamberi Fatjona,Bruijn Ria,Kokuri Tedi,Asimakopoulou Evanthia
Abstract
The COVID-19 pandemic has resulted in the worst public health catastrophe in recent history, impacting people's mental health and increasing concern over vaccinations. Between early May and late June 2021, a web-based survey that included higher education institutions from three countries (Albania, Belgium, and Cyprus) was conducted. The purpose was to assess the impact of the COVID-19 pandemic on the mental health of academic staff, what affects their readiness to get the COVID-19 vaccine, and whether there is a link between the country of residence and readiness to be vaccinated. The short version of the Depression, Anxiety, and Stress Score (DASS) questionnaire and a section of questions on vaccination readiness supported by the Health Belief Model were used for data collection. The final study sample was composed of 87 academics, both in Albania (n = 57) and in European Union (EU) countries (n = 30). Females comprised 91.2% of the Albanian participants and 63.3% of the EU countries participants. 89.7% of Albanian participants reported significantly higher proportions of prior COVID-19 (p = 0.001), compared to only 10.3% of EU country participants. Participants from Albania were less likely to vaccinate family members against COVID-19, and there was a significant association between this finding and whether an institution was affiliated with the EU (p = 0.007). In the two study groups, the DASS indicators showed a significant association between stress (p = 0.012) and depression (p = 0.011). The findings indicated that the pandemic affected the academic staff's mental health. When compared to academic staff members working in the EU, Albanian participants exhibited a larger prevalence of moderate-to-extremely severe depression and stress, which had an impact on their intentions to vaccinate against COVID-19. The results are essential to developing mental health coping strategies and approaches for increasing vaccination uptake, especially in developing countries.
Subject
Cellular and Molecular Neuroscience,Neurology (clinical),Developmental Neuroscience,Neurology
Reference47 articles.
1. Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents. 2020; 55: 105924.
2. WHO Coronavirus (COVID-19) dashboard [Internet]. Geneva, Switzerland: WHO; 2022. Available from: https://covid19.who.int/.
3. EMA recommends first COVID-19 vaccine for authorisation in the EU [Internet]. Amsterdam, Netherlands: EMA; 2020. Available from: https://www.ema.europa.eu/en/news/ema-recommends-first-covid-19-vaccine-authorisation-eu.
4. Hall VJ, Foulkes S, Saei A, Andrews N, Oguti B, Charlett A, et al. COVID-19 vaccine coverage in health-care workers in England and effectiveness of BNT162b2 mRNA vaccine against infection (SIREN): A prospective, multicentre, cohort study. Lancet. 2021; 397: 1725-1735.
5. Randolph HE, Barreiro LB. Herd immunity: Understanding COVID-19. Immunity. 2020; 52: 737-741.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献